ARUP Newsroom

Jonathan Genzen, MD, PhD, MBA, ARUP’s chief medical officer and senior director of governmental affairs, along with three coauthors, created a detailed resource summarizing existing federal laws and regulations in the context of anatomic pathology.

Benjamin Bradley, MD, PhD, medical director of the ARUP Institute for Research and Innovation in Infectious Disease Genomic Technologies, High Consequence Pathogen Response, Virology, and Molecular Infectious Diseases, participated in a media briefing about the measles virus with the College of American Pathologists.

Research highlights will include applications of RNA sequencing, long-read whole genome sequencing, and cytogenetics in the identification of rare and undiagnosed diseases, confirmation of novel variants, the curation of standardized reports for pharmacogenetics testing, and more.

The robotic arm removes the wet-mount specimen slide in preparation for scanning. Once scanned, the image will be screened via artificial intelligence (AI) for evidence of ova and parasites.

Tracy I. George, MD, ARUP Laboratories’ chief scientific officer and president of the Innovation Business Unit, detailed ARUP’s commitment to cutting-edge diagnostic research during a Rare Disease Day event hosted at Recursion on February 27. The podium featured a zebra, the mascot of people with rare diseases. 

ARUP CEO Andy Theurer, Chief Scientific Officer Tracy George, and BioHive leaders watch a video featuring George after ARUP received the Best of BioHive Community Impact Award on Thursday.

The U.S. District Court for the Eastern District of Texas in Plano on Wednesday heard oral arguments on motions for summary judgment in a legal challenge of the FDA’s authority to regulate laboratory-developed tests.